(EAY 131-U MATCH): VS-6063 (defactinib) in Patients with Tumors with NF2 Loss
Description: 

The purpose of this study is to test any good and bad effects of the study drug, defactinib in patients whose cancer has genetic changes in NF2.

Study Number: 

NCG 275215 U

Phase: 
2
Principal Investigator: 
ClinicalTrials.Gov ID: 
NCT02465060

To inquire about participating in these studies, call 1-877-ASK-RPCI (1-877-275-7724) or e-mail askrpci@roswellpark.org.